# Final Fatal Flaw Gate

| Check | Answer |
|---|---|
| A. Any confirmed train-test preprocessing leakage in final manuscript evidence? | NO. Old GraphSAGE full-node scaling was found, patched, rerun for external train-only evidence, and DLPFC GraphSAGE was removed from V4 main evidence. |
| B. Any test-set-driven target selection? | NO. Moran targets define the task; no prediction-performance target selection. |
| C. Any patient overlap in patient-held-out split? | NO for datasets reported as patient-held-out. |
| D. Any test performance used for hyperparameter tuning? | NO. Fixed parameters and validation-only early stopping. |
| E. Any seed cherry-picking? | NO. Frozen seed sets; incomplete DLPFC GraphSAGE correction excluded. |
| F. Any spot-level pseudoreplication used for formal claims? | NO. Spot-level metrics are descriptive; inferential framing is seed/fold/slide/dataset level. |
| G. Any external-validation claim that is slide-level only? | NO. Visium breast and GSE278936 are explicitly bounded. |
| H. Any result in V4 inconsistent with frozen or Phase 19 corrected CSV? | NO. |

## Decision

**PASS.**
